|
Real-time Estimate
Tradegate
03:50:45 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 58.70 EUR | -0.25% |
|
+1.64% | -7.40% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.45B | |||||
| 1,038B | |||||
| 649B | - | ||||
| 467B | |||||
| 355B | |||||
| 269B |
Select your edition
All financial news and data tailored to specific country editions
